Swedish Orphan Biovitrum Ab opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Swedish Orphan Biovitrum Ab

Patent Number:
Title:
Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity
Opposition Date:
Dec 17, 2021
Patent Number:
Title:
Sodium Chloride Solution For Drug Reconstitution Or Dilution
Applicant:
Opposition Date:
May 14, 2020
Patent Number:
Title:
Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation Factor
Opposition Date:
Dec 13, 2019

Competitors of Swedish Orphan Biovitrum Ab

CSL BEHRING GMBH

WYETH LLC

Want to track Swedish Orphan Biovitrum Ab?

Feel free to send us a message here and we will get back to you